Cüneyt Orhan Kara, Fazıl Necdet Ardıç, Erdem Mengi, Pınar Çakmak, Funda TÜMKAYA

Cost Analysis of Contrast Enhancement in Magnetic Resonance Imaging for Screening Retrocochlear Pathologies in Asymmetric Hearing Loss

Objective: Contrast-enhanced temporal magnetic resonance imaging (MRI) is the gold standard for differential diagnosis of retrocochlear pathologies. Nowadays, with the improvement of MRI devices and new imaging modalities, we have very detailed images of the cerebellopontine angle. In this study, we calculated the additional cost of contrast-enhanced MRI and questioned that if contrast-enhanced imaging is still necessary for diagnosis. Methods: Temporal bone MRIs of 1145 patients admitted to our clinic with unilateral asymmetric sensorineural hearing loss were evaluated retrospectively. The factors that affect the cost of the imaging, including serum creatinine test, establishing vascular access, and contrast material were analyzed, both for the cost and the time consumed. Results: Of the 1145 patients, 31 were diagnosed with vestibular schwannoma (VS). Re-examination of the images of the patients with VS revealed that the tumor could be seen on the images with and without contrast in 30 cases. Only one patient had a tiny VS that was difficult to identify on noncontrast imaging. The total additional time and cost for contrast-enhanced imaging were calculated as 18,320 minutes and 37,888 USD. The sensitivity and specificity of the noncontrast 3D FIESTA technique have been determined as 96.8% and 99.9%, respectively. Conclusion: We recommend the noncontrast MRI 3D FIESTA modality for screening because of its high sensitivity and specificity when the cost and time spent for contrast enhancement are taken into account. It will also reduce the expenses of the health system, increase hospital income, and shorten waiting lists of patients

PDF

___

1. Lin FR, Niparko JK, Ferrucci L. Hearing loss prevalence in the United States. Archives of internal medicine. 2011; 171(20): 1851-1852. [Crossref]
2. Niskar AS, Kieszak SM, Holmes A, Esteban E, Rubin C, Brody DJ. Prevalence of hearing loss among children 6 to 19 years of age: The third national health and nutrition examination survey. JAMA. 1998; 279(14): 1071-1075. [Crossref]
3. Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015;1 24(2): 223-228. [Crossref]
4. Fujita T, Saito K, Kashiwagi N, Sato M, Seo T, Doi K. The prevalence of vestibular schwannoma among patients treated as sudden sensorineural hearing los s. Auris Nasus Larynx. 2019 46(1): 78-82. [Crossref]
5. Fortnum H, O’Neill C, Taylor R, et al. The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: A systematic review of clinical and cost effectiveness and natural history. Health Technol Assess. 2009; 13(18): 1-154. [Crossref]
6. Sweeney AD, Carlson ML, Shepard NT, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on otologic and audiologic screening for patients with vestibular schwannomas. Neurosurgery. 2018; 82: 29-30. [Crossref]
7. Allen RW, Harnsberger HR, Shelton C, et al. Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: An alternative to enhanced conventional spin-echo MR?. AJNR Am J Neuroradiol. 1996; 17(7): 1205-1210.
8. Stuckey SL, Harris AJ, Mannolini SM. Detection of acoustic schwannoma: Use of constructive interference in the steady state three dimensional MR. AJNR Am J Neuroradiol. 1996; 17: 1219-1225.
9. Nadol JB. Cerebellopontine angle tumors. In: Nadol BN, Schuknecht HF editors. Surgery of the ear and temporal bone. New York: Raven Press Ltd; 1993. p. 391-412.
10. Nadol JB, Diamond JPF, Thornton AR. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic neuroma). Am J Otol. 1996; 17: 312-315.
11. Kwan TL, Tang KW, Pak KK, Cheung JY. Screening for vestibular schwannoma by magnetic resonance imaging: Analysis of 1821 patients. Hong Kong Med J. 2004; 10: 38-43.
12. Held P, Fründ R, Seitz J, et al. Comparison of a T2* W. 3D CISS and a T2 w. 3D turbo spin echo sequence for the anatomical study of facial and vestibulocochlear nerves. J Neuroradiol. 2000; 27: 173-178.
13. Ryan M, Weissman JL, Kaylie D. Is Gadolinium contrast enhancement necessary in screening MRI for asymmetric sensorineural hearing loss? Laryngoscope. 2015 (4); 125: 783-784. [Crossref]
14. Hatipoğlu HG, Durakoğlugil T, Ciliz D, Yüksel E. Comparison of FSE T2W and 3D FIESTA sequences in the evaluation of posterior fossa cranial nerves with MR cisternography. Diagn Interv Radiol. 2007; 13: 56-60.